SHILPAMED.NSSHILPAMED.NSNSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank50
3Y CAGR+7.3%
5Y CAGR-1.7%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+7.3%/yr
vs -5.5%/yr prior
5Y CAGR
-1.7%/yr
Recent acceleration
Acceleration
+12.8pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 24.16% | +13.3% |
| 2024 | 21.33% | +96.1% |
| 2023 | 10.87% | -44.4% |
| 2022 | 19.56% | -35.4% |
| 2021 | 30.29% | +15.0% |
| 2020 | 26.34% | +2.1% |
| 2019 | 25.80% | +5.4% |
| 2018 | 24.48% | -4.4% |
| 2017 | 25.60% | -2.7% |
| 2016 | 26.30% | - |